Yale School of Medicine (YSM) scientists have discovered a molecular difference in the brains of autistic people compared to ...

Researchers at University of Tsukuba and their collaborators have conducted a comprehensive analysis of the olfactory ...

In the CAPItello-291 trial of capivasertib plus fulvestrant, 73% of patients had already received a CDK4/6 inhibitor. As ...

Why do some people get drunk more quickly and feel more impaired? Biology and genetics play a role but alcohol’s effects on the brain are complex ...

The U.S. Food and Drug Administration's approval of an oral version of Novo Nordisk's weight-loss drug Wegovy could ...

Opioid receptors are a subset of G protein–coupled receptors (GPCRs). These membrane proteins transmit signals into the cell ...

Scientists at MIT and Stanford have unveiled a promising new way to help the immune system recognize and attack cancer cells ...

And modern research is showing we may actually have dozens of senses. Odours in low-fat yogurts can make them feel richer and ...

The FDA approved a pill version of the GLP-1 receptor agonist semaglutide (Wegovy), making it the first oral GLP-1 agent ...

This is the latest study to suggest that GLP-1s, particularly semaglutide, are tied to a reduced risk for epilepsy in type 2 diabetes.

My long-term collaborator, professor Charles Spence from the Crossmodal Laboratory in Oxford, told me his neuroscience ...

Medications developed to control blood sugar are now at the center of a very different scientific story: how they might raise ...